We previously showed that the dysregulation of ErbB receptor tyrosine kinases appears to be an important early initiation step in the development of diabetes-induced vascular dysfunction that involves increased gene-expression and enhanced phosphorylation of EGFR and ErbB2 receptor tyrosine kinases [4–5, 7–9]. Here, ERBB2 is linked to diabetes mellitus.